Adagene (ADAG) Prepaid Assets (2019 - 2026)
Adagene (ADAG) posted quarterly Prepaid Assets of $2834.0 billion for Q4 2025, up 10.05% year-over-year from $2575.2 billion in Q4 2024, and up 111895030.96% quarter-over-quarter from $2.5 million in Q2 2025.
Adagene (ADAG) Prepaid Assets (2019 - 2026) Analysis & Trends
Adagene (ADAG) has reported Prepaid Assets for 7 consecutive years, with $2834.0 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 10.05% year-over-year to $2834.0 billion; the TTM figure through Dec 2025 stood at $2834.0 billion (up 10.05% YoY), while the FY2025 annual figure was $2834.0 billion, up 10.05% from the prior year.
- Prepaid Assets climbed to $2834.0 billion in Q4 2025 per ADAG's latest filing, from $2.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $5107.3 billion in Q2 2022 and bottomed at $2.5 million in Q2 2025.
- Historically, Prepaid Assets has averaged $2226.6 billion across 5 years, with a median of $2704.6 billion in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 121731141.81% — and 2024, when it sank 100.0%.
- Adagene's Prepaid Assets stood at $4.1 million in 2021, then surged by 121731141.81% to $4937.3 billion in 2022, then slumped by 33.42% to $3287.4 billion in 2023, then fell by 21.67% to $2575.2 billion in 2024, then rose by 10.05% to $2834.0 billion in 2025.
- Business Quant data shows ADAG's Prepaid Assets at $2834.0 billion in Q4 2025, $2.5 million in Q2 2025, and $2575.2 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Adagene | 310.54 Mn | 310.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.35 Mn |
| Dec 31, 2025 | 2,834.03 Bn |
| Jun 30, 2025 | 2.53 Mn |
| Dec 31, 2024 | 2,575.19 Bn |
| Jun 30, 2024 | 3.10 Mn |
| Dec 31, 2023 | 3,287.45 Bn |
| Jun 30, 2023 | 3,524.69 Bn |
| Dec 31, 2022 | 4,937.32 Bn |
| Jun 30, 2022 | 5,107.27 Bn |
| Dec 31, 2021 | 4.06 Mn |
| Jun 30, 2021 | 5.39 Mn |
| Dec 31, 2020 | 3.81 Mn |
| Dec 31, 2019 | 1.48 Mn |